Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Practice

Lambert–Eaton myasthenic syndrome

Monique D'Amour, Gilles Gariepy and Joseph Braidy
CMAJ January 02, 2007 176 (1) 37; DOI: https://doi.org/10.1503/cmaj.060767
Monique D'Amour
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Gariepy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Braidy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading
  • © 2006 CMA Media Inc. or its licensors

What's your call?

Figure

Figure. A 72-year-old female smoker presented with morning fatigue, discrete left ptosis and absent reflexes in lower limbs. Top panel: Electromyogram showing evoked motor response of abductor of the fifth finger after stimulation of the left ulnar nerve with a 50-mA current at 50 Hz. Bottom panel: CT of thorax of the same patient 5 years later.

Repetitive electric stimulation at 50-Hz applied to the ulnar nerve at the wrist normally elicits from the abductor of the fifth finger an evoked response of ≥ 5 mV, which may increase no more than 50%. In the case we describe, the electromyogram (EMG) showed that the initial low-amplitude potential was at 0.54 mV and increased progressively to 1.82 mV, a change of 237%. This EMG pattern is a diagnostic feature of Lambert–Eaton myasthenic syndrome (LEMS).

When the patient first presented, she had an unremarkable plain chest radiograph. An initial CT of the thorax showed noncalcified mediastinal lymphadenopathy. Lymph node biopsy revealed a malignant neuroendocrine tumour, but the patient refused treatment. Five years later, a repeat CT of the thorax (Fig. 1) showed calcified subcarinal lymphadenopathy (small arrow) and a new 3.1-cm nodule in the left lower lobe (large arrow). These findings are consistent with a primary bronchogenic carcinoma, which had not been apparent initially. The level of antibodies to the P/Q-type voltage-gated calcium channels was high on presentation, at 1595 (normal < 20) pmol/L; it was still elevated 5 years later, at 881 pmol/L.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Fig. 1: CT of thorax 5 years after presentation, showing calcified subcarinal lymphadenopathy (black arrow) and new 3.1-cm nodule in left lower lobe (white arrow).

LEMS is most often a paraneoplastic syndrome associated with small-cell carcinoma, which it may precede. Like myasthenia gravis, it is an autoimmune disorder. Unlike myasthenia gravis, the weakness improves with exertion, and oculobulbar involvement is rare except for ptosis.

As in our case, EMG is diagnostic of LEMS when it shows incremental increases in muscle action potential in response to repetitive nerve stimulation. EMG helps to differentiate LEMS from other causes of cancer-associated weakness, such as myopathy and polyneuropathy. Detection of antibodies to the P/Q-type voltage-gated calcium channels expressed by the tumour and present on the presynaptic neuron of the neuromuscular junction is also diagnostic of LEMS.

Monique D'Amour Department of Neurology Gilles Gariepy Department of Pathology Joseph Braidy Department of Respiratory Diseases Hôpital Saint-Luc Centre hospitalier universitaire de Montréal Montréal, Que.

Footnotes

  • Competing interests: None declared.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 176 (1)
CMAJ
Vol. 176, Issue 1
2 Jan 2007
  • Table of Contents
  • Index by author
  • Canadian Adverse Reaction Newsletter (p 125-132)

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lambert–Eaton myasthenic syndrome
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lambert–Eaton myasthenic syndrome
Monique D'Amour, Gilles Gariepy, Joseph Braidy
CMAJ Jan 2007, 176 (1) 37; DOI: 10.1503/cmaj.060767

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Lambert–Eaton myasthenic syndrome
Monique D'Amour, Gilles Gariepy, Joseph Braidy
CMAJ Jan 2007, 176 (1) 37; DOI: 10.1503/cmaj.060767
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • SARS-CoV-2 vaccination in pregnancy
  • Infantile perianal pyramidal protrusion
  • Topical nonsteroidal anti-inflammatory drugs
Show more Practice

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire